These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 20055428

  • 1. Titanocene difluorides with improved cytotoxic activity.
    Eger S, Immel TA, Claffey J, Müller-Bunz H, Tacke M, Groth U, Huhn T.
    Inorg Chem; 2010 Feb 15; 49(4):1292-4. PubMed ID: 20055428
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma.
    Köpf-Maier P.
    Anticancer Res; 1999 Feb 15; 19(1A):493-504. PubMed ID: 10226588
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A new generation of anticancer drugs: mesoporous materials modified with titanocene complexes.
    Pérez-Quintanilla D, Gómez-Ruiz S, Zizak Z, Sierra I, Prashar S, del Hierro I, Fajardo M, Juranić ZD, Kaluderović GN.
    Chemistry; 2009 Feb 15; 15(22):5588-97. PubMed ID: 19370742
    [Abstract] [Full Text] [Related]

  • 9. Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175.
    Hayward RL, Schornagel QC, Tente R, Macpherson JS, Aird RE, Guichard S, Habtemariam A, Sadler P, Jodrell DI.
    Cancer Chemother Pharmacol; 2005 Jun 15; 55(6):577-83. PubMed ID: 15726367
    [Abstract] [Full Text] [Related]

  • 10. [Effect of ZGDHu-1 on proliferation and apoptosis of A549 cells in vitro and antitumor activity in vivo].
    Zhou YL, Hu WX, Lü YP, Qiu LN, Wang WS, Yang ZY, Liu JD, Rao GW.
    Yao Xue Xue Bao; 2007 Jan 15; 42(1):26-34. PubMed ID: 17520803
    [Abstract] [Full Text] [Related]

  • 11. Synthesis, molecular characterization, and biological activity of novel synthetic derivatives of chromen-4-one in human cancer cells.
    Barve V, Ahmed F, Adsule S, Banerjee S, Kulkarni S, Katiyar P, Anson CE, Powell AK, Padhye S, Sarkar FH.
    J Med Chem; 2006 Jun 29; 49(13):3800-8. PubMed ID: 16789737
    [Abstract] [Full Text] [Related]

  • 12. FTY720 induced Bcl-associated and Fas-independent apoptosis in human renal cancer cells in vitro and significantly reduced in vivo tumor growth in mouse xenograft.
    Ubai T, Azuma H, Kotake Y, Inamoto T, Takahara K, Ito Y, Kiyama S, Sakamoto T, Horie S, Muto S, Takahara S, Otsuki Y, Katsuoka Y.
    Anticancer Res; 2007 Jun 29; 27(1A):75-88. PubMed ID: 17352219
    [Abstract] [Full Text] [Related]

  • 13. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.
    Vogler M, Walczak H, Stadel D, Haas TL, Genze F, Jovanovic M, Gschwend JE, Simmet T, Debatin KM, Fulda S.
    Cancer Res; 2008 Oct 01; 68(19):7956-65. PubMed ID: 18829553
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of human experimental prostate cancers by a targeted cytotoxic luteinizing hormone-releasing hormone analog AN-207.
    Stangelberger A, Schally AV, Nagy A, Szepeshazi K, Kanashiro CA, Halmos G.
    Prostate; 2006 Feb 01; 66(2):200-10. PubMed ID: 16173040
    [Abstract] [Full Text] [Related]

  • 15. Effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) in combination with paclitaxel (Taxol) on prostate Cancer LNCaP cells cultured in vitro or grown as xenograft tumors in immunodeficient mice.
    Zheng X, Chang RL, Cui XX, Avila GE, Hebbar V, Garzotto M, Shih WJ, Lin Y, Lu SE, Rabson AB, Kong AN, Conney AH.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3444-51. PubMed ID: 16740769
    [Abstract] [Full Text] [Related]

  • 16. A novel ruthenium(II) arene based intercalator with potent anticancer activity.
    Ruiz J, Vicente C, de Haro C, Bautista D.
    Dalton Trans; 2009 Jul 14; (26):5071-3. PubMed ID: 19562164
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Potential new antitumor agents from an innovative combination of camphorato, a ramification of traditional Chinese medicine, with a platinum moiety.
    Wang L, Gou S, Chen Y, Liu Y.
    Bioorg Med Chem Lett; 2005 Jul 15; 15(14):3417-22. PubMed ID: 15953727
    [Abstract] [Full Text] [Related]

  • 19. CpG immunomer DNA enhances antisense protein kinase A RIalpha inhibition of multidrug-resistant colon carcinoma growth in nude mice: molecular basis for combinatorial therapy.
    Nesterova MV, Johnson NR, Stewart T, Abrams S, Cho-Chung YS.
    Clin Cancer Res; 2005 Aug 15; 11(16):5950-5. PubMed ID: 16115938
    [Abstract] [Full Text] [Related]

  • 20. Casiopeina III-ia induces apoptosis in HCT-15 cells in vitro through caspase-dependent mechanisms and has antitumor effect in vivo.
    Carvallo-Chaigneau F, Trejo-Solís C, Gómez-Ruiz C, Rodríguez-Aguilera E, Macías-Rosales L, Cortés-Barberena E, Cedillo-Peláez C, Gracia-Mora I, Ruiz-Azuara L, Madrid-Marina V, Constantino-Casas F.
    Biometals; 2008 Feb 15; 21(1):17-28. PubMed ID: 17390215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.